PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Tullis Health Investors hires director of investor relations and marketing

Tullis Health Investors, a private equity and venture capital fund manager that oversees a family of funds focused on investments in biotech, pharmaceutical, medical device, medical service and other healthcare companies, has appointed Michael Cleary as director of investor relations and marketing.

 
Prior to joining Tullis Health Investors, Cleary was a managing director with Equus Financial Consultants & Crossbay Capital Partners. Previously, he was a managing director in the private funds group at JP Morgan/Bear Stearns, raising third party private equity and real estate funds from institutional and high net worth investors.
 
Prior to that, Cleary was a general partner and executive director with BNY Mellon-West LB Asset Management, where he was also a member of the investment committee, head of US sales and marketing, and a deal team leader for fund investments as well as co-investments. Cleary was previously a managing director at Thomas Capital Group, a boutique private equity placement firm.
 
Cleary brings over 30 years of diversified investment and financial experience in the private equity sector as a general partner, executive director, limited partner and private equity portfolio manager. He has spent the past 18 years of his career in the US and international private equity markets, and maintains a significant network of institutional investors, partners, consultants, advisers and intermediaries with whom he will continue to work closely.
 
Cleary has served on numerous limited partnership advisory boards and investment advisory committees and has held various board positions in private companies and co-investments. He was also one of the original founding members of the Institutional Limited Partners’ Association (ILPA), which today represents a significant number of institutional investors on a global basis.
 
“I am extremely excited to be joining Tullis Health Investors at this time, and contributing to its success and its expansion in the rapidly growing and dynamic healthcare sector worldwide. Healthcare spending is now 17 per cent of US GDP and continues to grow. We anticipate significant changes in the US healthcare delivery model with many opportunities for profitable investing. Our population is ageing, our technology is continuing to advance, and our needs for healthy solutions and for effective and cost efficient solutions have never been greater. I believe Tullis is well positioned, with its track record of successful investing in the healthcare industry, its team of experienced investment personnel and its broad connections and unique perspectives,” says Cleary.
 
“Mike’s extensive and varied background should be a great complement to Tullis,” says Tullis founder and chief executive Jim Tullis. “He brings broad insights, as a CPA, having been controller of a large pension organisation, then working as a limited partner when he managed alternative investments at VRS, and still later being a general partner in a successful fund-of-funds. Mike also has extensive relationships throughout the investment community and valuable perspectives, reflecting his role as a co-founder of ILPA. Mike will lead investor relations and marketing at Tullis, which will be a great fit given his many strengths. We look forward to his contributions to our team and to our investors.”

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured